Looking for Options for your Prostate Cancer?
If you are one of the 40,000 men treated for prostate cancer with
radiation only to have their cancer return, then this clinical trial
may be of interest to you.
This study might be appropriate if you:
• Are between the age of 40 and 85
• Have organ confined (biopsy confirmed) recurrent prostate cancer
(Clinical Stages T1c and T2a)
• Have been treated with EBRT (conventional, 3D conformal, or IMRT)
two or more years prior
• Have not had any prior medical or surgical treatment for prostate
cancer, other than EBRT or hormone therapy
• Meet other protocol specific inclusion criteria
The purpose of this clinical research study is to evaluate the
effectiveness of a study device, Sonablate® 500, which uses High
Intensity Focused Ultrasound, HIFU, for the treatment of subjects who
have locally recurrent prostate cancer. The high intensity focused
ultrasound (sound wave energy) acts to destroy diseased tissue in the
prostate. This treatment is radiation-free and has fewer side effects
than other cancer treatments including hormone therapy.
The procedure is minimally invasive and is performed in an outpatient
setting. You will be seen in the clinic a total of up to 10 times
over 1 year, to ensure the procedure has been successful.
For more information or to determine if you qualify for this research
opportunity, please call toll-free 1-866-619-6026 or visit
www.theprostatecancerstudy.com/go.aspx
No comments:
Post a Comment